Related Experiment Video
Updated: Nov 21, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Performance-based risk-sharing agreements in renal care: current experience and future prospects
Michael Drummond1,2, Carlo Federici2, Ellen Busink3
1Centre for Health Economics, University of York, York, UK.
Performance-based risk-sharing agreements (PBRSAs) can facilitate new technology adoption despite design challenges. Overcoming these hurdles in renal care can benefit patients, providers, and manufacturers by enabling access to advanced treatments and care models.
Area of Science:
- Health economics
- Health services research
- Medical technology assessment
Background:
- Performance-based risk-sharing agreements (PBRSAs) are valuable tools when the cost-effectiveness of new health technologies is uncertain.
- These agreements, involving payers, providers, and manufacturers, can be complex to design and implement effectively.
- Existing PBRSAs primarily focus on national-level, provider-payer pay-for-performance schemes.
Purpose of the Study:
- To explore the potential and challenges of PBRSAs in healthcare.
- To identify opportunities for PBRSAs, particularly at the local level between providers and manufacturers.
- To illustrate the application of PBRSAs through hypothetical case studies.
Main Methods:
- A comprehensive literature review was conducted to identify existing PBRSAs.
- Analysis of 18 identified agreements to understand their structure and scope.
- Development of hypothetical case studies to demonstrate potential PBRSA applications.
Main Results:
- The literature review identified 18 PBRSAs, predominantly national-level pay-for-performance agreements between providers and payers.
- No examples of local-level agreements between healthcare providers and manufacturers were found.
- Hypothetical case studies highlighted the potential of local PBRSAs in areas like water quality and chronic kidney disease management.
Conclusions:
- PBRSAs offer advantages for patients, providers, payers, and manufacturers, especially in introducing novel technologies or care systems.
- Significant challenges exist in the design, conduct, and implementation of PBRSAs, particularly within renal care.
- Addressing these challenges is crucial to ensure broader patient access to technological advancements and innovative care models in renal medicine.
Related Concept Videos
Renal Drug Clearance: Overview
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...

